Evaluating the Anticancer Activity of Blocking TNF Type 1 Receptors in Thioacetamide-Induced Hepatocellular Carcinoma in a Rat Model

Background Hepatocellular carcinoma (HCC) can explicate about 90% of the total primary liver cancer cases, with approximately 800,000 new cases identified each year worldwide. In addition, any changes in the expression of the tumor necrosis factor α (TNF-α) type 1 receptor (TNFR1) might impact many...

Descripción completa

Detalles Bibliográficos
Autores principales: Bagalagel, Alaa, Diri, Reem, Noor, Ahmed, Almasri, Deina, Bakhsh, Hussain, Kutbi, Hussam I, Al-Gayyar, Mohammed M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749874/
https://www.ncbi.nlm.nih.gov/pubmed/36531792
http://dx.doi.org/10.7759/cureus.32519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749874/
https://www.ncbi.nlm.nih.gov/pubmed/36531792
http://dx.doi.org/10.7759/cureus.32519

Ejemplares similares